Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Assessing analgesic use in patients with advanced cancer: development of a new scale--the Analgesic Quantification Algorithm.

Chung KC, Barlev A, Braun AH, Qian Y, Zagari M.

Pain Med. 2014 Feb;15(2):225-32. doi: 10.1111/pme.12299. Epub 2014 Jan 8.

2.

Intrasession reproducibility of RNFL thickness measurements using SD-OCT in eyes with keratoconus.

Reibaldi M, Uva MG, Avitabile T, Toro MD, Zagari M, Mariotti C, Cennamo G, Reibaldi A, Longo A.

Ophthalmic Surg Lasers Imaging. 2012 Nov-Dec;43(6 Suppl):S83-9. doi: 10.3928/15428877-20121001-04.

PMID:
23357329
3.

Foveal microstructure and functional parameters in lamellar macular hole.

Reibaldi M, Parravano M, Varano M, Longo A, Avitabile T, Uva MG, Zagari M, Toro M, Boscia F, Boccassini B, Chiaravalloti A, Mariotti C, Reibaldi A.

Am J Ophthalmol. 2012 Dec;154(6):974-980.e1. doi: 10.1016/j.ajo.2012.06.008. Epub 2012 Sep 8.

PMID:
22967862
4.

Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg.

Reibaldi M, Russo A, Zagari M, Toro M, Grande De V, Cifalinò V, Rametta S, Faro S, Longo A.

Case Rep Ophthalmol. 2012 Jan;3(1):30-4. doi: 10.1159/000336273. Epub 2012 Jan 31.

5.

Integrating pain metrics into oncology clinical trials.

Cleeland CS, O'Mara A, Zagari M, Baas C.

Clin Cancer Res. 2011 Nov 1;17(21):6646-50. doi: 10.1158/1078-0432.CCR-11-1109.

6.

Functional retinal changes measured by microperimetry in standard-fluence vs low-fluence photodynamic therapy in chronic central serous chorioretinopathy.

Reibaldi M, Boscia F, Avitabile T, Uva MG, Russo A, Zagari M, Occhipinti F, Russo V, Reibaldi A, Longo A.

Am J Ophthalmol. 2011 Jun;151(6):953-960.e2. doi: 10.1016/j.ajo.2010.12.007. Epub 2011 Mar 31.

PMID:
21457929
7.

Ten Years of Severe Vitreomacular Traction Syndrome without Functional Damage Demonstrated by Optical Coherence Tomography.

Reibaldi M, Avitabile T, Uva MG, Occhipinti F, Toro M, Zagari M, Russo A.

Case Rep Ophthalmol Med. 2011;2011:931038. doi: 10.1155/2011/931038. Epub 2011 Sep 8.

8.

Enhanced depth imaging optical coherence tomography of the choroid in idiopathic macular hole: A cross-sectional prospective study.

Reibaldi M, Boscia F, Avitabile T, Uva MG, Russo V, Zagari M, Bonfiglio V, Reibaldi A, Longo A.

Am J Ophthalmol. 2011 Jan;151(1):112-117.e2. doi: 10.1016/j.ajo.2010.07.004. Epub 2010 Oct 20.

PMID:
20970113
9.

Market exclusivity for biologics.

Pollock A, Zagari M.

N Engl J Med. 2010 Feb 18;362(7):661; author reply 661-2. No abstract available.

PMID:
20187263
10.

Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial.

Reibaldi M, Cardascia N, Longo A, Furino C, Avitabile T, Faro S, Sanfilippo M, Russo A, Uva MG, Munno F, Cannemi V, Zagari M, Boscia F.

Am J Ophthalmol. 2010 Feb;149(2):307-315.e2. doi: 10.1016/j.ajo.2009.08.026. Epub 2009 Nov 6.

PMID:
19896635
11.

Compliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter?

Curkendall S, Patel V, Gleeson M, Campbell RS, Zagari M, Dubois R.

Arthritis Rheum. 2008 Oct 15;59(10):1519-26. doi: 10.1002/art.24114.

12.

Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence.

Perri F, Piepoli A, Bonvicini C, Gentile A, Quitadamo M, Di Candia M, Cotugno R, Cattaneo F, Zagari MR, Ricciardiello L, Gennarelli M, Bazzoli F, Ranzani GN, Andriulli A.

Cytokine. 2005 Jun 7;30(5):293-302. Epub 2005 Apr 2.

PMID:
15927855
13.

Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease.

Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D.

J Am Soc Nephrol. 2005 Jul;16(7):2180-9. Epub 2005 May 18.

14.

Changes in cost-effectiveness over time. The case of Epoetin Alfa for renal replacement therapy patients in the UK.

Remák E, Hutton J, Jones M, Zagari M.

Eur J Health Econ. 2003;4(2):115-21.

PMID:
15609178
15.

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis.

Jones M, Ibels L, Schenkel B, Zagari M.

Kidney Int. 2004 Mar;65(3):757-67.

16.

Evaluation of quality of life in a clinical trial with nonrandom dropout: the effect of epoetin alfa in anemic cancer patients.

Fairclough DL, Gagnon DD, Zagari MJ, Marschner N, Dicato M; Epoetin Alfa Study Group.

Qual Life Res. 2003 Dec;12(8):1013-27.

PMID:
14651419
17.
18.

Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa.

Patrick DL, Gagnon DD, Zagari MJ, Mathijs R, Sweetenham J; Epoetin Alfa Study Group.

Eur J Cancer. 2003 Feb;39(3):335-45.

PMID:
12565986
19.

Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population.

Cella D, Zagari MJ, Vandoros C, Gagnon DD, Hurtz HJ, Nortier JW.

J Clin Oncol. 2003 Jan 15;21(2):366-73.

PMID:
12525531
20.

A population-based survey on gastrointestinal tract symptoms and Helicobacter pylori infection in children and adolescents.

De Giacomo C, Valdambrini V, Lizzoli F, Gissi A, Palestra M, Tinelli C, Zagari M, Bazzoli F.

Helicobacter. 2002 Dec;7(6):356-63.

PMID:
12485122
21.

Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy.

Fallowfield L, Gagnon D, Zagari M, Cella D, Bresnahan B, Littlewood TJ, McNulty P, Gorzegno G, Freund M; Epoetin Alfa Study Group.

Br J Cancer. 2002 Dec 2;87(12):1341-53.

22.

Age, anemia, and fatigue.

Aapro MS, Cella D, Zagari M.

Semin Oncol. 2002 Jun;29(3 Suppl 8):55-9. Review.

PMID:
12082655
23.

A cost analysis of diabetic lower-extremity ulcers.

Harrington C, Zagari MJ, Corea J, Klitenic J.

Diabetes Care. 2000 Sep;23(9):1333-8.

24.

What can be learnt from the new data about antibiotic resistance? Are there any practical clinical consequences of Helicobacter pylori antibiotic resistance?

Bazzoli F, Berretti D, De Luca L, Nicolini G, Pozzato P, Fossi S, Zagari M.

Eur J Gastroenterol Hepatol. 1999 Aug;11 Suppl 2:S39-42; discussion S43-5.

PMID:
10503822
25.

Diagnosis of Helicobacter pylori infection: non-invasive diagnostic tests.

Bazzoli F, Zagari M, Pozzato P, Fossi S, Ricciardiello GL, Nicolini G, De Luca L, Berretti D, Maltoni S, Martuzzi C, Roda E.

Ital J Gastroenterol Hepatol. 1998 Oct;30 Suppl 3:S313-4. Review.

PMID:
10077763
26.

The cost-effectiveness of octreotide acetate in the treatment of carcinoid syndrome and VIPoma.

Schonfeld WH, Eikin EP, Woltering EA, Modlin IM, Anthony L, Villa KF, Zagari M.

Int J Technol Assess Health Care. 1998 Summer;14(3):514-25.

PMID:
9780538
27.

Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis.

Bazzoli F, Pozzato P, Zagari M, Fossi S, Ricciardiello L, Nicolini G, Berretti D, De Luca L.

Helicobacter. 1998 Sep;3(3):195-201.

PMID:
9731991
28.

Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.

Ricciardiello L, Cannizzaro O, D'Angelo A, Ederle A, Gerace G, Iaquinto G, Reina G, Scarpulla G, Spadaccini A, Olivieri A, Tosatto R, Fossi S, Pozzato P, Zagari M, Bazzoli F, Roda E.

Aliment Pharmacol Ther. 1998 Jun;12(6):533-7.

29.

Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.

Pozzato P, Zagari M, Cardelli A, Catalano FA, Giglio A, Lami F, Pilotto A, Scarpulla G, Spadaccini A, Susi D, Tosatto R, Olivieri A, Bazzoli F, Roda E.

Aliment Pharmacol Ther. 1998 May;12(5):447-51.

30.

Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study.

Bazzoli F, Zagari M, Pozzato P, Varoli O, Fossi S, Ricciardiello L, Alampi G, Nicolini G, Sottili S, Simoni P, Roda A, Roda E.

Aliment Pharmacol Ther. 1998 May;12(5):439-45.

31.

Costs and duration of care for lower extremity ulcers in patients with diabetes.

Holzer SE, Camerota A, Martens L, Cuerdon T, Crystal-Peters J, Zagari M.

Clin Ther. 1998 Jan-Feb;20(1):169-81. Erratum in: Clin Ther 1998 Mar-Apr;20(2):373.

PMID:
9522113
32.

Urea breath tests for the detection of Helicobacter pylori infection.

Bazzoli F, Zagari M, Fossi S, Pozzato P, Ricciardiello L, Mwangemi C, Roda A, Roda E.

Helicobacter. 1997 Jul;2 Suppl 1:S34-7. Review.

PMID:
9432352
33.

Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori.

Taylor JL, Zagari M, Murphy K, Freston JW.

Arch Intern Med. 1997 Jan 13;157(1):87-97.

PMID:
8996045
34.

Nitroarenes of photochemical origin: a possible source of risk to human health.

Cecinato A, Zagari M.

J Environ Pathol Toxicol Oncol. 1997;16(2-3):93-9.

PMID:
9275989
35.
36.

Dexrazoxane cardioprotection for patients receiving FAC chemotherapy: a pharmacoeconomic evaluation.

Tonkin K, Bates M, Lieu D, Arundell E, Williamson T, Zagari M.

Can J Oncol. 1996 Nov;6(2):458-73.

PMID:
12056098
37.

Pharmacoeconomics of chronic nonmalignant pain.

Zagari MJ, Mazonson PD, Longton WC.

Pharmacoeconomics. 1996 Oct;10(4):356-77. Review.

PMID:
10163578
38.

Shortening the time between availability of new medical information and its adoption in general practice.

Mazonson P, Zagari M, Freston JW.

Med Interface. 1996 Mar;9(3):71-7. No abstract available.

PMID:
10156016
39.

[Effects of therapy with bis-hemisuccinate of ursodeoxycholic acid bisodium salt in patients with chronic hepatitis].

Pinto A, Parini P, Novelli V, Zagari M, Sangermano A, Orsini M, Salzetta A, Buffarini F, Roda E.

Minerva Med. 1992 Jun;83(6):359-61. Italian.

PMID:
1352868
40.
41.

The electric cadaver.

Zagari M.

JAMA. 1989 Feb 3;261(5):781, 783. No abstract available.

PMID:
2642984
42.

Inhibition of early platelet-derived growth factor responses in BALB/c-3T3 cells by interferon.

Zagari M, Hepler JR, Harris C, Herman B.

Biochem Biophys Res Commun. 1988 Feb 15;150(3):1207-12. Erratum in: Biochem Biophys Res Commun 1988 Mar 30;151(3):1461.

PMID:
2449206

Supplemental Content

Loading ...
Support Center